activities · 1 group
What they do
-
U.S.-Japan Cultural and Educational Exchange 1 activity
- Promote pharmaceutical industry understanding between the USA and JapanPromotes better understanding of the pharmaceutical industry between the USA and Japan through dialogue, research, and collaboration.
-
financials · form 990 · fy2021
revenue
Total revenue$2
Contributions & grants$00%
Program service revenue$00%
Investment income$2100%
Other revenue$0
expenses
Total expenses$1K
Program expenses0%
Admin / overhead100%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineProfessional Fees
balance sheet
Total assets$113K
Cash$29K
Investments$0
Liabilities$187K
Net assets$-74K
Liquid reserves254.8 mo
3 years on record · 2019–2021 · YoY revenue -50.0%
leadership · form 990 part vii · fy2021
Who runs it
board members · 13
- Dr Alex Chang — Director
- Dr Hiroshi Kawai — Director
- Dr Jeffrey Warmke — Director
- Dr John Keller — President
- Dr Rana Al-Hallaq — Director
- Dr Toby Freyman — Director
- Mr Kazumi Taguchi — Director
- Mr Mitsu Kosaka — Secretary
- Mr Sang Le — Director
- Mr Shoji Yasuda — Director
- Mr Tuyen Do — Director
- Ms Brianne Weingarten — Vice President
- Ms Theresa Covert — Director
strategies · 1
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Binational Knowledge Exchangemethodology: binational_knowledge_exchangeBy facilitating structured knowledge sharing between U.S. and Japanese pharmaceutical sectors, we improve mutual understanding of regulatory, innovation, and market dynamics, because cross-border learning accelerates industry advancement and informs better policy and practice.